Max Jousma is an equity analyst, healthcare, for Morningstar.* He covers European medical technology firms.
Before joining Morningstar in February 2024, Jousma was an equity analyst at Qmulus, where he covered a variety of sectors, including semiconductors and technology.
Jousma holds a master’s degree in finance from the Vrije Universiteit Amsterdam and a master’s degree in data science from the University of Amsterdam. He also has passed Level I of the Chartered Financial Analyst® program.
* Morningstar Holland BV (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc.
United States